LP
RVMDW icon

LMR Partners’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

LMR Partners’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,185,658
Closed -$306K – 1546
2024
Q3 		$306K Buy
+2,185,658
New +$266K ﹤0.01% 912

Other funds holding RVMDW

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

LMR Partners's RVMDW Position: Q1 2026 in Review

LMR Partners increased its Revolution Medicines Inc Warrant (RVMDW) stake by 22% in Q1 2026, buying an estimated $1.33M and bringing the position to 3,838,024 shares worth $6.87M. The position accounts for 0.02% of the portfolio, ranked #542.

LMR Partners first reported a position in RVMDW in Q1 2024 and has held it in 8 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • LMR Partners held 3,838,024 shares of Revolution Medicines Inc Warrant worth $6.87M as of Q1 2026.
  • LMR Partners bought 686,319 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $1.33M.
  • Revolution Medicines Inc Warrant made up 0.02% of LMR Partners's portfolio in Q1 2026, its #542 holding.
  • LMR Partners first reported a position in Revolution Medicines Inc Warrant in Q1 2024 and has held it in 8 quarters since.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.